You May Also Like

COVID-19 Outbreak Among Attendees of an Exercise Facility — Chicago, Illinois, August–September 2020
Cite
CITE Title : COVID-19 Outbreak Among Attendees of an Exercise Facility — Chicago, Illinois, August–September 2020 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 02/24/2021 Series : MMWR. Morbidity and mortality supplementary materials Source : MMWR Morb Mortal Wkly Rep. 2021 Mar 5;70(9):321-325 URL : https://stacks.cdc.gov/view/cdc/103076 Centers for Disease Control and Prevention (U.S.) (2021). COVID-19 Outbreak Among Attendees of an Exercise Facility — Chicago, Illinois, August–September 2020. 70(9). Centers for Disease Control and Prevention (U.S.) "COVID-19 Outbreak Among Attendees of an Exercise Facility — Chicago, Illinois, August–September 2020" 70, no. 9 (2021) Centers for Disease Control and Prevention (U.S.) "COVID-19 Outbreak Among Attendees of an Exercise Facility — Chicago, Illinois, August–September 2020" vol. 70, no. 9, 2021 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 108.26 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
02/24/2021 | MMWR. Morbidity and mortality supplementary materials
Description:
MMWR Supplementary Table for: Suggested citation for this article: Lendacki FR, Teran RA, Gretsch S, Fricchione MJ, Kerins JL. COVID-19 Outbreak Among...
File Type:
[PDF - 108.26 KB]
File Type:
[PDF - 108.26 KB]

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
Cite
CITE Title : Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 04/30/2021 Series : MMWR. Morbidity and mortality supplementary materials URL : https://stacks.cdc.gov/view/cdc/105473 Centers for Disease Control and Prevention (U.S.) (2021). Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021. 70(18). Centers for Disease Control and Prevention (U.S.) "Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021" 70, no. 18 (2021) Centers for Disease Control and Prevention (U.S.) "Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021" vol. 70, no. 18, 2021 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 104.68 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
04/30/2021 | MMWR. Morbidity and mortality supplementary materials
Description:
SUPPLEMENTARY TABLE. Demographic characteristics of v-safe respondents who received Janssen COVID-19 vaccine and completed at least one health survey ...
File Type:
[PDF - 104.68 KB]
File Type:
[PDF - 104.68 KB]